Dietary choline reverses some, but not all, effects of folate deficiency on neurogenesis and apoptosis in fetal mouse brain.
In mice, maternal dietary folate, a cofactor in 1-carbon metabolism, modulates neurogenesis and apoptosis in the fetal brain. Similarly, maternal dietary choline, an important methyl-donor, also influences these processes. Choline and folate are metabolically interrelated, and we determined whether choline supplementation could reverse the effects of folate deficiency on brain development. Timed-pregnant mice were fed control (CT), folate-deficient (FD), or folate-deficient, choline-supplemented (FDCS) AIN-76 diets from d 11 to 17 (E11-17) of pregnancy, and on E17, fetal brains were collected for analysis. Compared with the CT group, the FD group had fewer neural progenitor cells undergoing mitosis in the ventricular zones of the developing mouse brain septum (47%; P < 0.01), hippocampus (29%; P < 0.01), striatum (34%; P < 0.01), and anterior and mid-posterior neocortex (33% in both areas; P < 0.01). In addition, compared with CT, the FD diet almost doubled the rate of apoptosis in the fetal septum and hippocampus (P < 0.01). In the FDCS group, the mitosis rates generally were intermediate between those of the CT and FD groups; mitosis rates in the septum and striatum were significantly greater compared with the FD group and were significantly lower than in the CT group only in the septum and neocortex. In the FDCS group, the hippocampal apoptosis rate was significantly lower than in the FD group (P < 0.01) and was the same as in the CT group. In the septum, the apotosis rate in the FDCS group was intermediate between the CT and FD groups' rates. These results suggest that neural progenitor cells in fetal forebrain are sensitive to maternal dietary folate during late gestation and that choline supplementation can modify some, but not all, of these effects.
Craciunescu
Corneliu N
CN
Department of Nutrition, School of Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Johnson
Amy R
AR
Zeisel
Steven H
SH
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D001921:Brain / Q000166:cytology / Q000187:drug effects / Q000196:embryology*; D002794:Choline / Q000494:pharmacology*; D005260:Female; D005333:Fetus / Q000187:drug effects; D005494:Folic Acid Deficiency / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D055495:Neurogenesis / Q000187:drug effects*; D011247:Pregnancy
D002794:Choline
Hum Mol Genet. 2006 Mar 1;15(5):705-16
16421170
J Histochem Cytochem. 1999 Feb;47(2):229-36
9889258
Am J Physiol Cell Physiol. 2000 Dec;279(6):C1889-95
11078704
FASEB J. 2010 Jan;24(1):184-95
19752176
Adv Exp Med Biol. 1994;352:157-72
7832045
J Comp Neurol. 1990 Nov 15;301(3):325-42
2262594
J Nutr. 1977 Jul;107(7):1340-8
874577
FASEB J. 2001 Aug;15(10):1704-10
11481217
Birth Defects Res C Embryo Today. 2007 Sep;81(3):183-203
17963270
J Nutr. 1995 Dec;125(12):3049-54
7500183
Jikken Dobutsu. 1989 Jul;38(3):245-52
2792207
J Nutr. 2009 Dec;139(12):2402-5
19812215
J Histochem Cytochem. 2001 Dec;49(12):1565-72
11724904
Development. 1997 Mar;124(6):1239-49
9102310
Brain Res Mol Brain Res. 2005 Apr 4;134(2):309-22
15836926
Neuropathol Appl Neurobiol. 1996 Dec;22(6):489-94
9004234
J Cell Physiol. 2002 May;191(2):173-82
12064460
J Nutr. 1999 Jan;129(1):25-31
9915871
Biomed Pharmacother. 2001 Oct;55(8):434-42
11686576
Epidemiology. 2006 May;17(3):285-91
16570024
FASEB J. 2006 Jan;20(1):43-9
16394266
FASEB J. 2003 Mar;17(3):512-4
12551843
J Biol Chem. 2001 Nov 2;276(44):41197-204
11483591
Oncogene. 2001 May 28;20(24):3021-7
11420717
Brain Res Dev Brain Res. 1999 Jun 2;115(2):123-9
10407130
Am J Epidemiol. 2004 Jul 15;160(2):102-9
15234930
N Engl J Med. 1992 Dec 24;327(26):1832-5
1307234
Cancer Res. 1991 Jan 1;51(1):16-21
1988081
Prog Neurobiol. 1995 Oct;47(2):135-55
8711131
FASEB J. 1999 Jan;13(1):135-42
9872938
J Nutr. 2003 Nov;133(11):3614-8
14608083
Carcinogenesis. 1997 Feb;18(2):287-93
9054620
Brain Res Dev Brain Res. 1997 Jul 18;101(1-2):9-16
9263575
Endocr Rev. 1993 Apr;14(2):133-51
8325248
Anat Rec. 1970 Feb;166(2):257-61
5414696
J Nutr. 2002 Jul;132(7):1840-7
12097657
Genesis. 2006 Sep;44(9):401-6
16868943
J Nutr. 2004 Jan;134(1):162-6
14704311
Nutr Rev. 2001 Jul;59(7):215-24
11475447
Am J Epidemiol. 2003 Apr 1;157(7):583-91
12672677
J Nutr. 1994 Nov;124(11):2197-203
7965204
J Neurobiol. 1996 Jul;30(3):315-28
8807525
Annu Rev Nutr. 1994;14:269-96
7946521
Dev Neurosci. 2001;23(2):100-6
11509832
Am J Clin Nutr. 2009 May;89(5):1488S-1493S
19261726
JAMA. 1995 Dec 6;274(21):1698-702
7474275
Clin Chim Acta. 1985 Jun 30;149(1):1-12
4028430
Brain Res Dev Brain Res. 1999 Mar 12;113(1-2):13-20
10064869
Brain Res. 1996 Sep 23;734(1-2):10-8
8896803
J Nutr. 1999 Apr;129(4):779-82
10203550
Neurosci Lett. 1994 Nov 21;182(1):77-9
7891894
FASEB J. 2001 Aug;15(10):1739-44
11481221
Neuron. 1996 Oct;17(4):579-85
8893016